Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01032
|
|||||
| Drug Name |
Metolazone
|
|||||
| Synonyms |
2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide; 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazolinesulfonamide; 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide; Diulo; Metalazone; Metalozone; Metenix; Metolazona; Metolazona [INN-Spanish]; Metolazone (JAN/USP/INN); Metolazone [USAN:BAN:INN:JAN]; Metolazonum; Metolazonum [INN-Latin]; Microx; Mykrox; Mykrox (TN); Mykrox, Zaroxolyn, Diulo, Metolazone; Oldren; SR 720-22; SR-720-22; Xuret; Zaroxolyn; Zaroxolyn (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
| Congestive heart failure [ICD11: BD10] | Approved | [1] | ||||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C16H16ClN3O3S
|
|||||
| Canonical SMILES |
CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
|
|||||
| InChI |
InChI=1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23)
|
|||||
| InChIKey |
AQCHWTWZEMGIFD-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 17560-51-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 365.8 | Topological Polar Surface Area | 101 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
4.1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321392
, 11335450
, 11360689
, 11363350
, 11365912
, 11368474
, 11374036
, 11376636
, 11461661
, 11466140
, 11467260
, 11485578
, 11485799
, 11489557
, 11492044
, 11494270
, 14926227
, 24724532
, 26613200
, 26680432
, 26747536
, 26747537
, 26753589
, 26753590
, 29223276
, 46509058
, 47365083
, 47365084
, 47588891
, 47736365
, 47736366
, 47885305
, 48259128
, 4904668
, 49698717
, 50041173
, 50106417
, 50106418
, 50267110
, 56413187
, 56463247
, 56463561
, 57322175
, 7847497
, 7979975
, 8150176
, 8152610
, 85087884
, 85787877
, 90341106
|
|||||
| ChEBI ID |
CHEBI:64354
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | NCC | Transporter Info | Thiazide-sensitive sodium-chloride cotransporter | Substrate | [2] | |
| References | ||||||
| 1 | Metolazone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Inhibition of binding of [3H]metolazone to rat kidney membrane by stilbene disulfonates. Biochem Pharmacol. 1991 Jun 1;41(11):1745-50. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.